PDCD1 and cancer: In particular, programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte–associated antigen-4 (CTLA-4) are checkpoints which downregulate T cell activation, produced by cancer cells in order to escape from immunity system, producing immune tolerance [8,9].